Mannose-binding lectin in chronic hepatitis C in children

References

• Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003;40:423–9.
   PubMed Web of Science ®Google Scholar
• Jack DL, Turner MW. Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans 2003;31:753–7.
   PubMed Web of Science ®Google Scholar
• Gadjeva M, Takahashi K, Thiel S. Mannan-binding lectin- a soluble pattern recognition molecule. Mol Immunol 2004;41:113–21.
   PubMed Web of Science ®Google Scholar
• Ezekowitz RA, Shi L, Fraser I, Takahashi K. The mannose-binding lectin: an infection susceptibility gene. Adv Exp Med Biol 2005;560:99–103.
   PubMed Web of Science ®Google Scholar
• Neth O, Jack DL, Dodds AW, Holzel H. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000;68:688–93.
   PubMed Web of Science ®Google Scholar
• Tenner AJ, Robinson SL, Ezekowitz RA. Mannose binding protein (MBP) enhances mononuclear phagocyte function via a receptor that contains the 126,000 M (r) component of the C1q receptor. Immunity 1995;3:485–93.
   PubMed Web of Science ®Google Scholar
• Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 2001;180:86–99.
   PubMed Web of Science ®Google Scholar
• Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001;38:133–49.
   PubMed Web of Science ®Google Scholar
• Goffard A, Dubuisson J. Glycosylation of hepatitis C virus envelope proteins. Biochimie 2003;85:295–301.
   PubMed Web of Science ®Google Scholar
• Brown KS, Ryder SD, Irving WL, Sim RB, Hickling TP. Mannan binding lectin and viral hepatitis. Immunol Lett 2007;108:34–44.
   PubMed Web of Science ®Google Scholar
• Møller-Kristensen M, Thiel S, Sjöholm A, Matsushita M, Jensenius JC. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Int Immunol 2007;19:141–9.
   PubMed Web of Science ®Google Scholar
• Turner MW, Lipscombe RJ, Levinsky RJ. Mutations in the human mannose binding protein gene: their frequencies in three distinct populations and relationship to serum levels of the protein. Immunodeficiency 1993;4:285–7.
   PubMedGoogle Scholar
• Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 1995;85:660–7.
   PubMed Web of Science ®Google Scholar
• Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013–20.
   PubMed Web of Science ®Google Scholar
• Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998;161:3169–75.
   PubMed Web of Science ®Google Scholar
• Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis 2003;37:1496–505.
   PubMed Web of Science ®Google Scholar
• Dzwonek A, Novelli V, Bajaj-Elliott M, Turner M, Clapson M, Klein N. Mannose-binding lectin in susceptibility and progression of HIV-1 infection in children. Antivir Ther 2006;11:449–505.
   Web of Science ®Google Scholar
• Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696–9.
   PubMed Web of Science ®Google Scholar
• Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431–5.
   PubMed Web of Science ®Google Scholar
• Jack D, Bidwell J, Turner M, Wood N. Simultaneous genotyping for all three known structural mutations in the human mannose-binding lectin gene. Hum Mutat 1997;9:41–6.
   PubMed Web of Science ®Google Scholar
• WHO Report Hepatitis C Fact sheet N 164 Updated. July 2013. Available from www.who.int/mediacentre/factsheets/fs164/en/.
   Google Scholar
• Tarr AW, Urbanowicz RA, Ball JK. The role of humoral innate immunity in hepatitis C virus infection. Viruses 2012;4:1–27.
   PubMed Web of Science ®Google Scholar
• Segat L, Silva Vasconcelos LR, Montenegro de Melo F, Santos Silva B, Arraes LC, Moura P, et al. Association of polymorphisms in the first exon of mannose binding lectin gene (MBL2) in Brazilian patients with HCV infection. Clin Immunol 2007;124:13–17.
   PubMed Web of Science ®Google Scholar
• Alves Pedroso ML, Boldt AB, Pereira-Ferrari L, Steffensen R, Strauss E, Jensenius JC, et al. Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy. Clin Exp Immunol 2008;152:258–64.
   PubMed Web of Science ®Google Scholar
• Brown KS, Keogh MJ, Owsianka AM, Adair R, Patel AH, Arnold JN, et al. Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry. Protein Cell 2010;7:664–74.
   Web of Science ®Google Scholar
• Esmat S, Omran D, Sleem GA, Rashed L. Serum mannan-binding lectin in Egyptian patients with chronic hepatitis C: its relation to disease progression and response to treatment. Hepat Mon 2012;12:259–64.
   PubMed Web of Science ®Google Scholar
• Sasaki K, Tsutsumi A, Wakamiya N, Ohtani K, Suzuki Y, Watanabe Y, et al. Mannose-binding lectin polymorphisms in patients with hepatitis C virus infection. Scand J Gastroenterol 2000;35:960–5.
   PubMed Web of Science ®Google Scholar
• Vallinoto AC, da Silva RF, Hermes RB, Amaral IS, Miranda EC, Barbosa MS, et al. Mannose-binding lectin gene polymorphisms are not associated with susceptibility to hepatitis C virus infection in the Brazilian Amazon region. Hum Immunol 2009;70:754–7.
   PubMed Web of Science ®Google Scholar
• Koutsounaki E, Goulielmos GN, Koulentaki M, Choulaki C, Kouroumalis E, Galanakis E. Mannose-binding lectin MBL2 gene polymorphisms and outcome of hepatitis C virus-infected patients. J Clin Immunol 2008;28:495–500.
   PubMed Web of Science ®Google Scholar
• Halla MC, do Carmo RF, Silva Vasconcelos LR, Pereira LB, Moura P, de Siqueira ER, et al. Association of hepatitis C virus infection and liver fibrosis severity with the variants alleles of MBL2 gene in a Brazilian population. Hum Immunol 2010;71:883–7.
   PubMed Web of Science ®Google Scholar
• Brown KS, Keogh MJ, Tagiuri N, Grainge MJ, Presanis JS, Ryder SD, et al. Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex. Clin Exp Immunol 2007;147:90–8.
   PubMed Web of Science ®Google Scholar
• Kilpatrick DC, Delahooke TE, Koch C, Turner ML, Hayes PC. Mannan-binding lectin and hepatitis C infection. Clin Exp Immunol 2003;132:92–5.
   PubMed Web of Science ®Google Scholar
• Matsushita M, Hijikata M, Ohta Y, Iwata K, Matsumoto M, Nakao K, et al. Hepatitis C virus infection and mutations of mannose-binding lectin gene MBL. Arch Virol 1998;143:645–51.
   PubMed Web of Science ®Google Scholar
• Matsushita M, Hijikata M, Matsushita M, Ohta Y, Mishiro S. Association of mannose-binding lectin gene haplotype LXPA and LYPB with interferon-resistant hepatitis C virus infection in Japanese patients. J Hepatol 1998;29:695–700.
   PubMed Web of Science ®Google Scholar
• Dumestre-Perard C, Ponard D, Drouet C, Leroy V, Zarski JP, Dutertre N, et al. Complement C4 monitoring in the follow-up of chronic hepatitis C treatment. Clin Exp Immunol 2002;127:131–6.
   PubMed Web of Science ®Google Scholar